Cargando…

The Immunogenicity and Safety of a Combined DTaP-IPV//Hib Vaccine Compared with Individual DTaP-IPV and Hib (PRP~T) Vaccines: a Randomized Clinical Trial in South Korean Infants

Recommended infant vaccination in Korea includes DTaP-IPV and Hib vaccines administered as separate injections. In this randomized, open, controlled study we assessed the non-inferiority of immunogenicity of DTaP-IPV//Hib pentavalent combination vaccine (Pentaxim™) compared with licensed DTaP-IPV an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Jin Han, Lee, Hoan Jong, Kim, Kyung-Hyo, Oh, Sung Hee, Cha, Sung-Ho, Lee, Jin, Kim, Nam Hee, Eun, Byung Wook, Kim, Chang-Hwi, Hong, Young Jin, Kim, Hyun Hee, Lee, Kyung-Yil, Kim, Yae-Jean, Cho, Eun Young, Kim, Hee Soo, Guitton, Fabrice, Ortiz, Esteban
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974178/ https://www.ncbi.nlm.nih.gov/pubmed/27510380 http://dx.doi.org/10.3346/jkms.2016.31.9.1383

Ejemplares similares

Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
por: Wilck, Marissa B., et al.
Publicado: (2020)

DTaP-IPV-HepB-Hib Vaccine (Hexyon(®)): An Updated Review of its Use in Primary and Booster Vaccination
por: Syed, Yahiya Y.
Publicado: (2019)

Comparing the pertussis antibody levels of healthy children immunized with four doses of DTap-IPV/Hib (Pentaxim) combination vaccine and DTaP vaccine in Quzhou, China
por: Yin, Zhiying, et al.
Publicado: (2023)

Correction to: DTaP‑IPV‑HepB‑Hib Vaccine (Hexyon(®)): An Updated Review of its Use in Primary and Booster Vaccination
por: Syed, Yahiya Y.
Publicado: (2019)

A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India
por: Sharma, Hitt, et al.
Publicado: (2023)

1393. Factors Associated with Co-administration of Pentavalent DTaP-IPV/Hib and Monovalent Hepatitis B Vaccine in the United States (US)
por: Petigara, Tanaz, et al.
Publicado: (2020)

Simultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: A nationwide register based cohort study
por: Sørup, Signe, et al.
Publicado: (2016)

2702. Infants Vaccinated with a Fully-Liquid DTaP-IPV-Hib-HepB Vaccine Are Protected During the High-Risk Period for Haemophilus Influenzae Type B Disease
por: Wilck, Marissa B, et al.
Publicado: (2019)

Post-Marketing Safety Surveillance of a Childhood Pentavalent Diphtheria–Tetanus–Acellular Pertussis–Polio and Haemophilus influenzae Type B (DTaP-IPV//Hib) Vaccine in South Korea
por: Yang, Kuhyun, et al.
Publicado: (2022)

Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children
por: Lee, Soon Min, et al.
Publicado: (2019)

Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously
por: Ahonen, Anitta, et al.
Publicado: (2022)

Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015
por: Choe, Young June, et al.
Publicado: (2022)

Dose-Sparing Intradermal DTaP-sIPV Immunization With a Hollow Microneedle Leads to Superior Immune Responses
por: Zuo, Weilun, et al.
Publicado: (2021)

1112 A Phase III Study of the Safety, Tolerability and Immunogenicity of an Investigational Combination Vaccine against Diphtheria, Tetanus, Pertussis (DTaP5), Polio (IPV), Haemophilus influenzae type b (Hib; PRP-OMPC), and Hepatitis B (HepB) in US Infants
por: Marshall, Gary S., et al.
Publicado: (2014)

Improving childhood vaccination coverage rates: the case of fourth dose of DTaP
por: Clark, Sarah J., et al.
Publicado: (2020)

Risk Factors Associated with Children Missing the Fourth Dose of DTaP Vaccination
por: Zhao, Zhen
Publicado: (2015)

2698. Timing of Standalone Vaccine Administration in Infants Receiving DTaP-Based Combination Vaccines
por: Alemayehu, Berhanu, et al.
Publicado: (2019)

Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants
por: Tanaka, Yoshiyuki, et al.
Publicado: (2017)

Timing of Monovalent Vaccine Administration in Infants Receiving DTaP-based Combination Vaccines in the United States
por: Marshall, Gary S., et al.
Publicado: (2022)

Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months
por: Kosalaraksa, Pope, et al.
Publicado: (2018)

Mixing of diphtheria, tetanus, and acellular pertussis (DTaP) vaccines in a population of children in managed care
por: Masseria, Cristina, et al.
Publicado: (2015)

Myelin oligodendrocyte glycoprotein antibody-associated disease following DTaP vaccination: A case report
por: Zhang, Xin
Publicado: (2022)

Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries
por: George, Marina, et al.
Publicado: (2023)

BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studies
por: Broset, Esther, et al.
Publicado: (2021)

Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
por: Dowling, David J., et al.
Publicado: (2022)

Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models
por: Zhang, Yuntao, et al.
Publicado: (2022)

Incomplete Early Childhood Immunization Series and Missing Fourth DTaP Immunizations; Missed Opportunities or Missed Visits?
por: Robison, Steve G.
Publicado: (2012)

Mucosal Immunization with DTaP Confers Protection against Bordetella pertussis Infection and Cough in Sprague-Dawley Rats
por: Hall, Jesse M., et al.
Publicado: (2021)

1388. DTaP-containing combination vaccines use and adherence to the recommended infant-toddler vaccination series among privately insured children in the US
por: Loiacono, Matthew M, et al.
Publicado: (2020)

Genetic Variation in the Magnitude and Longevity of the IgG Subclass Response to a Diphtheria-Tetanus-Acellular Pertussis (DTaP) Vaccine in Mice
por: Mosley, Yung-Yi C., et al.
Publicado: (2019)

Effectiveness of DTaP Against Pertussis in ≤2-Year-Old Children — Linyi Prefecture, Shandong Province, China, 2017–2019
por: Zhu, Pinpin, et al.
Publicado: (2023)

Guillain Barré syndrome after combined diphtheria, tetanus, and acellular pertussis (DTaP) vaccine: A rare pediatric case report and review of literature
por: Pan, Meichen, et al.
Publicado: (2023)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
por: Lalwani, Sanjay K., et al.
Publicado: (2016)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study
por: Kim, Ki Hwan, et al.
Publicado: (2018)

Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine
por: Bayliss, Julianne, et al.
Publicado: (2020)

1089 Safety and Immunogenicity of DTaP-IPV (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliovirus Vaccine) Compared to DAPTACEL(®) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) + IPOL(®) (Poliovirus Vaccine Inactivated) as the 5th Dose in Children 4 to 6 Years of Age
por: Smith, Michael, et al.
Publicado: (2014)

Immunogenicity and safety of concomitant administration of the chinese inactivated poliovirus vaccine with the diphtheria-tetanus-acellular pertussis (DTaP) vaccine in children: A multicenter, randomized, non-inferiority, controlled trial
por: Sun, Xiang, et al.
Publicado: (2022)

A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration
Publicado: (2019)

1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants
por: Scheifele, David W., et al.
Publicado: (2014)

Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age
por: Silfverdal, Sven A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_thi6r4fkn9ih33k7ea9hoc1anf